APA (7th ed.) Citation

M, C., ES, D., JM, S., MH, C., ME, R., RD, P., . . . J, M. (2024). Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age. The New England journal of medicine, 390(24), 2239. https://doi.org/10.1056/NEJMoa2312282

Chicago Style (17th ed.) Citation

M, Chehade, et al. "Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age." The New England Journal of Medicine 390, no. 24 (2024): 2239. https://doi.org/10.1056/NEJMoa2312282.

MLA (9th ed.) Citation

M, Chehade, et al. "Dupilumab for Eosinophilic Esophagitis in Patients 1 to 11 Years of Age." The New England Journal of Medicine, vol. 390, no. 24, 2024, p. 2239, https://doi.org/10.1056/NEJMoa2312282.